# EDGAR Filing Document

**Accession Number:** 0001377936
**File Stem:** 0001213900-25-062058
**Filing Date:** 2025-7
**Character Count:** 43165
**Document Hash:** 0981857d18d5b26dc0572604fe0bdbf3
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-062058.hdr.sgml**: 20250708

**ACCESSION NUMBER**: 0001213900-25-062058

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20250708

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250708

**DATE AS OF CHANGE**: 20250708

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SARATOGA INVESTMENT CORP.
- **CENTRAL INDEX KEY:** 0001377936

**ORGANIZATION NAME:**
- **EIN:** 204876925
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 0228

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 814-00732
- **FILM NUMBER:** 251111105

**BUSINESS ADDRESS:**
- **STREET 1:** 535 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022
- **BUSINESS PHONE:** 212 750-3343

**MAIL ADDRESS:**
- **STREET 1:** 535 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GSC INVESTMENT CORP.
- **DATE OF NAME CHANGE:** 20070321

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GSC Investment LLC
- **DATE OF NAME CHANGE:** 20061011

?xml version='1.0' encoding='ASCII'?

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, DC 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d)**

**of the Securities Exchange Act of 1934**

**Date of report (Date of earliest event reported): July 8, 2025**

**SARATOGA INVESTMENT CORP.** 

**(Exact Name of Registrant as Specified in Charter)**

---

| | | |
|:---|:---|:---|
| **Maryland** | **814-00732** | **20-8700615** |
| **(State or Other Jurisdiction<br> of Incorporation)** | **(Commission File Number)** | **(IRS Employer<br> Identification No.)** |

---

---

| | |
|:---|:---|
| **535 Madison Avenue<br> New York, New York** | **10022** |
| **(Address of Principal Executive Offices)** | **(Zip Code)** |

---

**Registrant's telephone number, including area code (212) 906-7800**

**Not Applicable** 

**(Former Name or Former Address, if Changed Since Last Report)** 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (*see* General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, par value $0.001 per share | SAR | New York Stock Exchange |
| 6.0% Notes due 2027 | SAT | New York Stock Exchange |
| 8.0% Notes due 2027 | SAJ | New York Stock Exchange |
| 8.125% Notes due 2027 | SAY | New York Stock Exchange |
| 8.50% Notes due 2028 | SAZ | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 2.02. Results of Operations and Financial Condition.**

On July 8, 2025, Saratoga Investment Corp. issued a press release announcing its financial results for the quarter ended May 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information disclosed under this Item 2.02, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be deemed incorporated by reference into any filing made under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.

**Item 9.01. Financial Statements and Exhibits.**

(d) Exhibits

The following Exhibit 99.1 is being furnished herewith to this Current Report on Form 8-K:

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 99.1 | [Press Release dated July 8, 2025 of Saratoga Investment Corp.\*](ea024833302ex99-1_saratoga.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

\* The press release attached hereto as Exhibit 99.1 is "furnished" and not "filed," as described in Item 2.02 of this Current Report on Form 8-K.

**SIGNATURES** 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

SARATOGA INVESTMENT CORP.

---

| | | |
|:---|:---|:---|
| Date: July 8, 2025 | By: | /s/ Henri J. Steenkamp |
|  | Name: | Henri J. Steenkamp |
|  | Title: | Financial Officer, Chief Compliance Officer, Treasurer and Secretary |

---

## Exhibit 99.1

**Exhibit 99.1**

![](ex99-1_001.jpg)

**Saratoga Investment Corp. Announces Fiscal First** 

**Quarter 2026 Financial Results**

**Reports 17.9% Increase in Adjusted NII Per Share and 0.9% Increase in NAV from Previous Quarter**

**Quarterly ROE of 14.1% Generates LTM ROE of 9.3% and Beats the BDC Industry Average of 7.0%**

**NEW YORK, July 8, 2025** – Saratoga Investment Corp. (NYSE: SAR) ("Saratoga Investment" or "the Company"), a business development company ("BDC"), today announced financial results for its fiscal first quarter 2026 ended May 31, 2025.

<u>Summary Financial Information</u> 

The Company's summarized financial information is as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **For the three months ended and as of** | **For the three months ended and as of** | **For the three months ended and as of** |
| <br>**($ in thousands, except per share)** | **May 31, <br> 2025** | **February 28,<br> 2025** | **May 31,<br> 2024** |
| Assets Under Management (AUM) | 968318 | 978078 | 1095559 |
| Net Asset Value (NAV) | 396369 | 392666 | 367855 |
| NAV per share | 25.52 | 25.86 | 26.85 |
| Total Investment Income | 32319 | 31295 | 38678 |
| Net Investment Income (NII) per share | 0.66 | 0.56 | 1.05 |
| Adjusted NII per share | 0.66 | 0.56 | 1.05 |
| Earnings per share | 0.91 | (0.05) | 0.48 |
| Dividends per share (declared) | 0.75 | 0.74 | 0.74 |
| Return on Equity – last twelve months | 9.3% | 7.5% | 4.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;– annualized quarter | 14.1% | (0.7%) | 7.2% |
| Originations | 50086 | 41802 | 39301 |
| Repayments | 64330 | 15867 | 75703 |

---

Christian L. Oberbeck, Chairman and Chief Executive Officer of Saratoga Investment, commented, "This quarter's highlights include a 17.9% increase in adjusted NII per share from the previous quarter, continued growth of NAV, a strong return on equity beating the industry, two new portfolio company investments and most importantly, a continued solid performance from the core BDC portfolio in a volatile macro environment."

"Building on our strong dividend distribution history, we announced a base dividend of $0.25 per share per month, or $0.75 per share in aggregate for the second quarter of fiscal 2026. Our annualized second quarter dividend of $0.75 per share represents an 11.8% yield based on the stock price of $25.44 as of July 7, 2025, offering strong current income from an investment value standpoint. Our Q1 adjusted NII of $0.66 per share continues to reflect the impact of the past twelve-month trend of decreasing levels of short-term interest rates and spreads on Saratoga Investment's largely floating rate assets, and the continued impact of the recent repayments. This has resulted in $224.3 million of cash, as of May 31, 2025, available to be deployed accretively in investments or repay existing debt."

"During the quarter, we continued to see a slower level of deal volume and M&A activity in the lower middle market following the recent tariff developments that had a stifling effect on new debt issuances. Despite these macro factors, our portfolio had multiple debt repayments and an equity realization in Q1, in addition to healthy new originations. These realizations generated $2.9 million of realized gains, while we originated $50.1 million in two new portfolio companies and six follow-ons, as well as closing on new investments in multiple BB CLO debt securities. Our strong reputation and differentiated market positioning, combined with our ongoing development of sponsor relationships, continues to create attractive investment opportunities from high quality sponsors. We continue to remain prudent and discerning in terms of new commitments in the current volatile environment"

"Saratoga's overall performance is reflected in our key performance indicators this past quarter, including: (i) Q1 ROE of 14.1% generating LTM ROE of 9.3%, beating the BDC industry average of 7.0%, (ii) deleveraging from 159.6% regulatory leverage last year to 163.8% this year, due in part to the NAV increase of $28.5 million during the last twelve months ($367.9 million to $396.4 million), (iii) adjusted NII of $0.66 per share versus $0.56 per share last quarter, (iv) EPS of $0.91 per share, up from $(0.05) loss in the previous quarter, and (v) dividends of $0.75 per share, up $0.01 per share from $0.74 per share last year. Of note is that the change to monthly dividends resulted in the March and April dividend record dates that would normally have been a Q2 event both falling into this first quarter, adding a one-time additional $0.50 per share dividend to the second quarter. This increased the dividends for the quarter from $0.75 per share to $1.25 per share, thus reducing NAV per share by $0.50. Excluding this one-time occurrence resulting from the change in the dividend payment policy, NAV per share would have risen to $26.02 this quarter, reflecting a 0.6% increase.

"At the foundation of our strong operating performance is the high-quality nature, resilience and balance of our $968.3 million portfolio in the current environment. Where we have encountered significant challenges in four of our portfolio companies over the past eighteen months, we have completed decisive actions and resolved all four of these situations through two sales and two restructurings. Our current core non-CLO portfolio was marked up by $2.6 million this quarter, and the CLO and JV were marked down by $0.2 million. We also had $0.2 million of net appreciation in our new BB investments, $0.6 million net realized appreciation on an equity realization and numerous debt repayments that generated $2.2m of life-to-date realized gains, and further net realized gains of $0.7 million from escrow payments on the Netreo and Hema Terra investments, resulting in the fair value of the portfolio increasing by $3.8 million during the quarter. As of quarter-end, our total portfolio fair value was 2.1% below cost, while our core non-CLO portfolio was 1.7% above cost. The overall financial performance and solid earnings power of our current portfolio reflects strong underwriting in our growing portfolio companies and sponsors in well-selected industry segments."

"Additionally, during the quarter our net interest margin expanded meaningfully from $13.7 million last quarter to $15.6 million, driven by a $1.4 million increase in non-CLO interest income as the full benefit of Q4 originations was realized, while repayments largely occurred late in Q1. Average yields were relatively unchanged. This was further supported by a $0.5 million decrease in interest expense, reflecting the full quarter benefit of repaying $44 million in SBIC II debentures at year-end and the partial period impact of redeeming the $20 million 8.75% baby bond this quarter. In addition, the full-period impact of the 1.2 million shares issued through the ATM program in Q4, and the partial impact of the additional 0.2 million shares issued in Q1, resulted in a $0.04 per share dilution to NII per share."

"Our quarter-end cash position increased from $204.7 million last quarter to $224.3 million in the current quarter, a strong level of cash availability in a very volatile macro environment. This level of cash improves our current regulatory leverage of 163.8% to 188.1%, netting available cash against outstanding debt."

"Our overall credit quality for this quarter remained steady at 99.7% of credits rated in our highest category, with the two investments remaining on non-accrual status being Zollege and Pepper Palace, both of which have been successfully restructured, representing only 0.3% and 0.6% of fair value and cost, respectively. With 86.9% of our investments at quarter-end in first lien debt and generally supported by strong enterprise values and balance sheets in industries that have historically performed well in stressed situations, we believe our portfolio and company leverage is well structured for future economic conditions and uncertainty."

Mr. Oberbeck concluded, "As we continue to navigate the challenges posed by the current geopolitical landscape and the volatility seen in the broader macro environment, we remain confident in our experienced management team, robust pipeline, strong leverage structure, and high underwriting standards to continue to steadily increase the size, quality and investment performance of our portfolio over the long-term, and deliver exceptional risk adjusted returns to shareholders."

**<u>Discussion of Financial Results for the Quarter ended May 31, 2025:</u>**

● **AUM** as of May 31, 2025 was $968.3 million, a decrease of 11.6% from $1.095 billion as of May 31, 2024, and a decrease of 1.0% from $978.1 million as of last quarter.

● **Total investment income** for the three months ended May 31, 2025 was $32.3 million, a decrease of $6.4 million, or 16.4%, from $38.7 million for the quarter ended May 31, 2024, and an increase of $1.0 million, or 3.3%, as compared to $31.3 million for the quarter ended February 28, 2025. This quarter's investment income decrease as compared to last year was due to both this past year's interest base rate decreases as well as lower recent AUM levels, reflecting the significant net repayments the last six months. This quarter's sequential increase is driven by the full period impact of Q4 originations. Investment income reflects a weighted average interest rate on the core BDC portfolio of 11.5%, unchanged as compared to 11.5% as of February 28, 2025 and down from 12.6% as of May 31, 2024, with the yield reduction primarily reflecting SOFR base rate decreases over the past year.

● **Total expenses** for the quarter ended May 31, 2025, excluding interest and debt financing expenses, base management fees and incentive fees, and income and excise taxes, decreased $0.1 million to $2.8 million as compared to $2.9 million for the quarter ended May 31, 2025, and increased $1.4 million as compared to $1.4 million for the quarter ended February 28, 2025. This represented 0.8% of average total assets on an annualized basis, unchanged from last quarter and down from 1.0% last year.

● **Adjusted NII** for the quarter ended May 31, 2025, was $10.1 million, a decrease of $4.2 million, or 29.3%, from $14.3 million in the quarter ended May 31, 2024, and an increase of $2.1 million, or 26.2% from $8.0 million in the quarter ended February 28, 2025. This quarter's increase in adjusted NII as compared to the prior quarter was primarily due to the non-recurrence this quarter of the $2.4 million annual excise tax recognized last quarter. The decrease from the previous year was largely due to lower AUM and base interest rates, as previously noted.

● **NII Yield** as a percentage of average net asset value was 10.3% for the quarter ended May 31, 2025. Adjusted for the incentive fee accrual related to net capital gains, the NII Yield was also 10.3%. In comparison, adjusted NII Yield was 15.5% for the quarter ended May 31, 2024, and 8.4% for the quarter ended February 28, 2025.

● **NAV** was $396.4 million as of May 31, 2025, an increase of $28.5 million from $367.9 million as of May 31, 2024, and an increase of $3.7 million from $392.7 million as of February 28, 2025.

● **NAV per share** was $25.52 as of May 31, 2025, compared to $26.85 as of May 31, 2024, and $25.86 as of February 28, 2025.

● **Return on equity ("ROE")** for the last twelve months ended May 31, 2025 was 9.3%, up from 4.4% for the comparable period last year, and 7.5% for the twelve months ended February 28, 2025. ROE on an annualized basis for the quarter ended May 31, 2025, was 14.1%, up from 7.2% for the comparable period last year, and (0.7)% for the previous period ended February 28, 2025.

● **The weighted average common shares outstanding** for the quarter ended May 31, 2025 was 15.3 million, increasing from 14.5 million and 13.7 million for the quarters ended February 28, 2025 and May 31, 2024, respectively.

**<u>Portfolio and Investment Activity for the Quarter Ended May 31, 2025</u>**

● **Fair value of Saratoga Investment's portfolio** was $968.3 million, excluding $224.3 million in cash and cash equivalents, principally invested in 46 portfolio companies, one collateralized loan obligation fund (the "CLO"), one joint venture fund (the "JV"), and nine BB CLO debt investments.

● **Cost of investments** made during the quarter ended May 31, 2025 were $50.1 million, including two investments in new portfolio companies and six follow-ons.

● **Principal repayments** during the quarter ended May 31, 2025 were $64.3 million, including one equity realization, four full repayments of existing investments and five partial repayments of existing investments, plus debt amortization.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o For the quarter ended May 31, 2025, the fair value of the portfolio increased by $3.8 million of
net realized gains and unrealized appreciation, consisting of (1) $2.6 million net appreciation in our core non-CLO portfolio, including
Pepper Palace and Zollege, (ii) net unrealized depreciation in the CLO of $0.3 million, and net unrealized appreciation of $0.1 million
in the JV, (iii) $0.2 million of net unrealized appreciation in our new BB CLO debt investments, (iv) $0.6 million net realized appreciation
on our Identity investment equity realization and numerous debt repayments that generated $2.2 million of life-to-date realized gains,
and (v) further net realized gains of $0.7 million on escrow payments received on our Netreo and Hema Terra investments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o Since taking over management of the BDC in 2010, the Company has generated $1.26 billion of repayments
and sales of investments originated by Saratoga Investment, generating a gross unlevered IRR of 15.0%. Total investments originated by
Saratoga are $2.36 billion in 122 portfolio companies.

● **The overall portfolio composition** consisted of 86.9% of first lien term loans, 0.7% of second lien term loans, 1.7% of unsecured term loans, 2.8% of structured finance securities, and 7.9% of common equity.

● **The weighted average current yield** on Saratoga Investment's portfolio based on current fair values was 10.7%, which was comprised of a weighted average current yield of 11.3% on first lien term loans, 16.8% on second lien term loans, 10.6% on unsecured term loans, 15.6% on structured finance securities and 0.0% on equity interests.

**<u>Liquidity and Capital Resources</u>**

<u>Outstanding Borrowings:</u> 

● As of May 31, 2025, Saratoga Investment had a combined $70.0 million in outstanding combined borrowings under its $65.0 million senior secured revolving credit facility with Encina and its $75.0 million senior secured revolving credit facility with Live Oak.

● At the same time, Saratoga Investment had $131.0 million of SBA debentures in its SBIC II license outstanding, $39.0 million of SBA debentures in its SBIC III license outstanding, $269.4 million of listed baby bonds issued, $250.0 million of unsecured unlisted institutional bond issuances, four unlisted issuances of $32.0 million in total, and an aggregate of $224.3 million in cash and cash equivalents.

<u>Undrawn Borrowing Capacity:</u>

● With $70.0 million available under the two credit facilities and $224.3 million of cash and cash equivalents as of May 31, 2025, Saratoga Investment has a total of $294.3 million of undrawn credit facility borrowing capacity and cash and cash equivalents to be used for new investments or to support existing portfolio companies in the BDC and the SBIC.

● In addition, Saratoga Investment has $136.0 million in undrawn SBA debentures available from its existing SBIC III license.

● Availability under the Encina and Live Oak credit facilities can change depending on portfolio company performance and valuation. In addition, certain follow-on investments in SBIC II and the BDC will not qualify for SBIC III funding. Overall outstanding SBIC debentures are limited to $350.0 million across all active SBIC licenses.

● Total Saratoga Investment undrawn borrowing capacity is therefore $430.3 million.

● As of May 31, 2025, Saratoga Investment had $58.6 million of committed undrawn lending commitments and $77.7 million of discretionary funding commitments.

<u>Additionally:</u>

● Saratoga Investment has an active equity distribution agreement with Ladenburg Thalmann & Co. Inc., Raymond James and Associates, Inc, Lucid Capital Markets, LLC and Compass Point Research and Trading, LLC, through which the Company may offer for sale, from time to time, up to $300.0 million of common stock through an ATM offering.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o As of May 31, 2025, Saratoga Investment has sold 8,089,547 shares for gross proceeds of $214.3 million
at an average price of $26.37 for aggregate net proceeds of $212.6 million (net of transaction costs).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o During the three months ended May 31, 2025, Saratoga Investment sold a total of 244,831 shares for gross
proceeds of $6.4 million at an average price of $26.31 for aggregate net proceeds of $6.4 million (net of transaction costs).

**<u>Dividend</u>**

On June 12, 2025, Saratoga Investment announced that its Board of Directors declared a base quarterly dividend of $0.75 per share in aggregate for the second quarter of fiscal 2026, declaring the following three monthly $0.25 per share dividends for the quarter ended August 31, 2025:

---

| | | | |
|:---|:---|:---|:---|
| **Month** | **Amount Per<br> Share** | **Record Date** | **Payment Date** |
| June 2025 | $0.25 | July 8, 2025 | July 24, 2025 |
| July 2025 | $0.25 | August 6, 2025 | August 21, 2025 |
| August 2025 | $0.25 | September 5, 2025 | September 24, 2025 |

---

Shareholders have the option to receive payment of dividends in cash or receive shares of common stock, pursuant to the Company's DRIP. Shares issued under the Company's DRIP is issued at a 5% discount to the average market price per share at the close of trading on the ten trading days immediately preceding (and including) the payment date.

The following table highlights Saratoga Investment's dividend history over the past fourteen quarters:

---

| | | | |
|:---|:---|:---|:---|
| **Period (Fiscal Year ends Feb)** | **Base Dividend <br> Per Share** | **Special Dividend<br> Per Share** | **Total Dividend<br> Per Share** |
| Fiscal Q2 2026 (August 2025) | $0.25 |  | $0.25 |
| Fiscal Q2 2026 (July 2025) | $0.25 |  | $0.25 |
| Fiscal Q2 2026 (June 2025) | $0.25 |  | $0.25 |
| Fiscal Q1 2026 (May 2025) | $0.25 |  | $0.25 |
| Fiscal Q1 2026 (April 2025) | $0.25 |  | $0.25 |
| Fiscal Q1 2026 (March 2025) | $0.25 |  | $0.25 |
| ***Full Year Fiscal 2026*** | $***1.50*** |  | $***1.50*** |
| Fiscal Q4 2025 | $0.74 |  | $0.74 |
| Fiscal Q3 2025 | $0.74 | $0.35 | $1.09 |
| Fiscal Q2 2025 | $0.74 |  | $0.74 |
| Fiscal Q1 2025 | $0.74 |  | $0.74 |
| ***Full Year Fiscal 2025*** | $***2.96*** | $***0.35*** | $***3.31*** |
| Fiscal Q4 2024 | $0.73 |  | $0.73 |
| Fiscal Q3 2024 | $0.72 |  | $0.72 |
| Fiscal Q2 2024 | $0.71 |  | $0.71 |
| Fiscal Q1 2024 | $0.70 |  | $0.70 |
| ***Full Year Fiscal 2024*** | $***2.86*** | ***-*** | $***2.86*** |
| Fiscal Q4 2023 | $0.69 |  | $0.69 |
| Fiscal Q3 2023 | $0.68 |  | $0.68 |
| Fiscal Q2 2023 | $0.54 |  | $0.54 |
| Fiscal Q1 2023 | $0.53 |  | $0.53 |
| ***Full Year Fiscal 2023*** | **$*2.44*** |  ***-*** | **$*2.44*** |

---

**<u>Share Repurchase Plan</u>**

As of May 31, 2025, the Company purchased 1,035,203 shares of common stock, at the average price of $22.05 for approximately $22.8 million pursuant to its existing Share Repurchase Plan. During the three months ended May 31, 2025, the Company did not purchase any shares of common stock pursuant to its Share Repurchase Plan.

Previously, in fiscal year 2015, the Company announced the approval of an open market share repurchase plan (the "Share Repurchase Plan") that allows it to repurchase up to 200,000 shares of its common stock at prices below its NAV as reported in its then most recently published financial statements. Since then, the Share Repurchase Plan has been extended annually, and the Company has periodically increased the amount of shares of common stock that may be purchased under the Share Repurchase Plan, most recently to 1.7 million shares of common stock. On January 7, 2025, its Board of Directors extended the Share Repurchase Plan for another year to January 15, 2026.

**<u>Fiscal First Quarter 2026 Conference Call/Webcast Information</u>**

---

| | |
|:---|:---|
| **When:** | Wednesday, July 9, 2025 |
|  | 10:00 a.m. Eastern Time (ET) |
| **How:** | **Webcast:** Interested parties may access a live webcast of the call and find the Q1 2026 presentation by going to the "Events & Presentations" section of Saratoga Investment Corp.'s investor relations website (Saratoga events and presentations). A replay of the webcast will also be available for a limited time at Saratoga events and presentations. |
| **Call:** | To access the call by phone, please go to this link (Registration Link) and you will be provided with dial in details. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time |

---

<u>About Saratoga Investment Corp.</u>

Saratoga Investment is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests primarily in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Saratoga Investment's objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments. Saratoga Investment has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended, and is externally managed by Saratoga Investment Advisors, LLC, an SEC-registered investment advisor focusing on credit-driven strategies. Saratoga Investment Corp. owns two active SBIC-licensed subsidiaries, having surrendered its first license after repaying all debentures for that fund following the end of its investment period and subsequent wind-down. Furthermore, it manages a $650 million collateralized loan obligation ("CLO") fund that is in wind-down and co-manages a joint venture ("JV") fund that owns a $400 million collateralized loan obligation ("JV CLO") fund. It also owns 52% of the Class F and 100% of the subordinated notes of the CLO, 87.5% of both the unsecured loans and membership interests of the JV and 87.5% of the Class E notes of the JV CLO. The Company's diverse funding sources, combined with a permanent capital base, enable Saratoga Investment to provide a broad range of financing solutions.

<u>Forward Looking Statements</u>

This press release contains historical information and forward-looking statements with respect to the business and investments of the Company, including, but not limited to, the statements about future events or our future performance or financial condition. Forward-looking statements can be identified by the use of forward looking words such as "outlook," "believes," "expects," "potential," "continues," "may," "will," "should," "seeks," "approximately," "predicts," "intends," "plans," "estimates," "anticipates" or negative versions of those words, other comparable words or other statements that do not relate to historical or factual matters. The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. These statements are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including, but not limited to: changes in the markets in which we invest; changes in the financial, capital, and lending markets; an economic downturn or a recession and its impact on the ability of our portfolio companies to operate and the investment opportunities available to us; the impact of interest rate volatility on our business and our portfolio companies; the uncertainty associated with the imposition of tariffs and trade barriers and changes in trade policy and its impact on our portfolio companies and the global economy; the impact of supply chain constraints and labor shortages on our portfolio companies; and the elevated levels of inflation and its impact on our portfolio companies and the industries in which we invests, as well as those described from time to time in our filings with the Securities and Exchange Commission.

Any forward-looking statement speaks only as of the date on which it is made. The Company undertakes no duty to update any forward-looking statements made herein or on the webcast/conference call, whether as a result of new information, future developments or otherwise, except as required by law. Readers should not place undue reliance on any forward-looking statements and are encouraged to review the Company's Annual Report on Form 10-K for the fiscal year ended February 28, 2025 and subsequent filings, including the "Risk Factors" sections therein, with the Securities and Exchange Commission for a more complete discussion of the risks and other factors that could affect any forward-looking statements.

**Contacts**:

Saratoga Investment Corporation

535 Madison Avenue, 4th Floor

New York, NY 10022

Henri Steenkamp

Chief Financial Officer

Saratoga Investment Corp.

212-906-7800

Lena Cati

The Equity Group Inc.

212-836-9611

Val Ferraro

The Equity Group Inc.

212-836-9633

<u>Financials</u>

**Saratoga Investment Corp.**

**Consolidated Statements of Assets and Liabilities**

---

| | | |
|:---|:---|:---|
|  | **May 31, <br> 2025** | **February 28, <br> 2025** |
| ASSETS |  |  |
| Investments at fair value |  |  |
| &nbsp;&nbsp;&nbsp;Non-control/Non-affiliate investments (amortized cost of $863,450,463 and $886,071,934, respectively) | $875410787 | $897660110 |
| &nbsp;&nbsp;&nbsp;Affiliate investments (amortized cost of $49,725,886 and $38,203,811, respectively) | 52023563 | 40547432 |
| &nbsp;&nbsp;&nbsp;Control investments (amortized cost of $76,213,218 and $75,817,587, respectively) | 40883612 | 39870208 |
| Total investments at fair value (amortized cost of $989,389,567 and $1,000,093,332, respectively) | 968317962 | 978077750 |
| Cash and cash equivalents | 131562513 | 148218491 |
| Cash and cash equivalents, reserve accounts | 92724212 | 56505433 |
| Interest receivable (net of reserve of $264,278 and $210,319, respectively) | 8000745 | 7477468 |
| Management fee receivable | 294307 | 314193 |
| Other assets | 1369594 | 950522 |
| Total assets | $1202269333 | $1191543857 |
| LIABILITIES |  |  |
| Revolving credit facilities | $70000000 | $52500000 |
| &nbsp;&nbsp;&nbsp;Deferred debt financing costs, revolving credit facilities | (1037309) | (1254516) |
| SBA debentures payable | 170000000 | 170000000 |
| &nbsp;&nbsp;&nbsp;Deferred debt financing costs, SBA debentures payable | (3831484) | (4041026) |
| 8.75% Notes Payable 2025 |  | 20000000 |
| &nbsp;&nbsp;&nbsp;Discount on 8.75% notes payable 2025 |  | (9055) |
| &nbsp;&nbsp;&nbsp;Deferred debt financing costs, 8.75% notes payable 2025 |  | (374) |
| 7.00% Notes Payable 2025 | 12000000 | 12000000 |
| &nbsp;&nbsp;&nbsp;Discount on 7.00% notes payable 2025 | (35844) | (68589) |
| &nbsp;&nbsp;&nbsp;Deferred debt financing costs, 7.00% notes payable 2025 | (4346) | (8345) |
| 7.75% Notes Payable 2025 | 5000000 | 5000000 |
| &nbsp;&nbsp;&nbsp;Deferred debt financing costs, 7.75% notes payable 2025 | (5860) | (19685) |
| 4.375% Notes Payable 2026 | 175000000 | 175000000 |
| &nbsp;&nbsp;&nbsp;Premium on 4.375% notes payable 2026 | 226581 | 287848 |
| &nbsp;&nbsp;&nbsp;Deferred debt financing costs, 4.375% notes payable 2026 | (653235) | (865593) |
| 4.35% Notes Payable 2027 | 75000000 | 75000000 |
| &nbsp;&nbsp;&nbsp;Discount on 4.35% notes payable 2027 | (180419) | (213424) |
| &nbsp;&nbsp;&nbsp;Deferred debt financing costs, 4.35% notes payable 2027 | (601980) | (688786) |
| 6.25% Notes Payable 2027 | 15000000 | 15000000 |
| &nbsp;&nbsp;&nbsp;Deferred debt financing costs, 6.25% notes payable 2027 | (184171) | (202144) |
| 6.00% Notes Payable 2027 | 105500000 | 105500000 |
| &nbsp;&nbsp;&nbsp;Discount on 6.00% notes payable 2027 | (77798) | (87295) |
| &nbsp;&nbsp;&nbsp;Deferred debt financing costs, 6.00% notes payable 2027 | (1347571) | (1524089) |
| 8.00% Notes Payable 2027 | 46000000 | 46000000 |
| &nbsp;&nbsp;&nbsp;Deferred debt financing costs, 8.00% notes payable 2027 | (840029) | (927484) |
| 8.125% Notes Payable 2027 | 60375000 | 60375000 |
| &nbsp;&nbsp;&nbsp;Deferred debt financing costs, 8.125% notes payable 2027 | (1053557) | (1156234) |
| 8.50% Notes Payable 2028 | 57500000 | 57500000 |
| &nbsp;&nbsp;&nbsp;Deferred debt financing costs, 8.50% notes payable 2028 | (1170572) | (1273134) |
| Base management and incentive fees payable | 6869845 | 6230944 |
| Deferred tax liability | 4994417 | 4889329 |
| Payable from open trades | 6750000 |  |
| Accounts payable and accrued expenses | 1556106 | 1676335 |
| Interest and debt fees payable | 4598538 | 3909517 |
| Due to Manager | 553706 | 349189 |
| &nbsp;&nbsp;&nbsp;Total liabilities | 805900018 | 798878389 |
| Commitments and contingencies |  |  |
| NET ASSETS |  |  |
| Common stock, par value $0.001, 100,000,000 common shares authorized, 15,529,391 and 15,183,078 common shares issued and outstanding, respectively | 15529 | 15183 |
| Capital in excess of par value | 421664914 | 412913597 |
| Total distributable deficit | (25311128) | (20263312) |
| &nbsp;&nbsp;&nbsp;Total net assets | 396369315 | 392665468 |
| Total liabilities and net assets | $1202269333 | $1191543857 |
| NET ASSET VALUE PER SHARE | $25.52 | $25.86 |
| Asset Coverage Ratio | 163.8% | 162.9% |

---

**Saratoga Investment Corp.**

**Consolidated Statements of Operations**

**(unaudited)**

---

| | | |
|:---|:---|:---|
|  | **For the three months ended** | **For the three months ended** |
|  | **May 31, <br> 2025** | **May 31, <br> 2024** |
| INVESTMENT INCOME |  |  |
| Interest from investments |  |  |
| &nbsp;&nbsp;&nbsp;Interest income: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-control/Non-affiliate investments | $25464663 | $31224277 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Affiliate investments | 595624 | 496840 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Control investments | 1190661 | 1997112 |
| &nbsp;&nbsp;&nbsp;Payment in kind interest income: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-control/Non-affiliate investments | 168229 | 63830 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Affiliate investments | 584749 | 241104 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Control investments | - | 283313 |
| Total interest from investments | 28003926 | 34306476 |
| Interest from cash and cash equivalents | 2027211 | 624631 |
| Management fee income | 705175 | 804456 |
| Dividend income: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-control/Non-affiliate investments | 562183 | 249491 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Control investments | 436418 | 1297050 |
| Total dividend from investments | 998601 | 1546541 |
| Structuring and advisory fee income | 264375 | 410843 |
| Other income | 319329 | 985203 |
| &nbsp;&nbsp;&nbsp;Total investment income | 32318617 | 38678150 |
| OPERATING EXPENSES |  |  |
| Interest and debt financing expenses | 12451865 | 12962081 |
| Base management fees | 4333332 | 4982580 |
| Incentive management fees expense (benefit) | 2536513 | 3584734 |
| Professional fees | 699200 | 999310 |
| Administrator expenses | 1250000 | 1075000 |
| Insurance | 74310 | 77596 |
| Directors fees and expenses | 131500 | 113000 |
| General and administrative | 645411 | 609127 |
| Income tax expense (benefit) | 54454 | (60283) |
| &nbsp;&nbsp;&nbsp;Total operating expenses | 22176585 | 24343145 |
| NET INVESTMENT INCOME | 10142032 | 14335005 |
| REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS |  |  |
| Net realized gain (loss) from investments: |  |  |
| &nbsp;&nbsp;&nbsp;Non-control/Non-affiliate investments | 2262984 |  |
| &nbsp;&nbsp;&nbsp;Control investments | 638355 | (21194997) |
| Net realized gain (loss) from investments | 2901339 | (21194997) |
| Net change in unrealized appreciation (depreciation) on investments: |  |  |
| &nbsp;&nbsp;&nbsp;Non-control/Non-affiliate investments | 372148 | 14156825 |
| &nbsp;&nbsp;&nbsp;Affiliate investments | (45944) | 601223 |
| &nbsp;&nbsp;&nbsp;Control investments | 617773 | (826617) |
| Net change in unrealized appreciation (depreciation) on investments | 943977 | 13931431 |
| Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments | (55085) | (461001) |
| Net realized and unrealized gain (loss) on investments | 3790231 | (7724567) |
| NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS | $13932263 | $6610438 |
| WEIGHTED AVERAGE - BASIC AND DILUTED EARNINGS (LOSS) PER COMMON SHARE | $0.91 | $0.48 |
| WEIGHTED AVERAGE COMMON SHARES OUTSTANDING - BASIC AND DILUTED | 15344510 | 13683314 |

---

<u>Supplemental Information Regarding Adjusted Net Investment Income, Adjusted Net Investment Income Yield and Adjusted Net Investment Income per Share</u>

On a supplemental basis, Saratoga Investment provides information relating to adjusted net investment income, adjusted net investment income yield and adjusted net investment income per share, which are non-GAAP measures. These measures are provided in addition to, but not as a substitute for, net investment income, net investment income yield and net investment income per share, respectively. These non-GAAP measures should only be used to evaluate the Company's results of operations in conjunction with their corresponding GAAP measures. Adjusted net investment income represents net investment income excluding any capital gains incentive fee expense or reversal attributable to realized and unrealized gains. The management agreement with the Company's advisor provides that a capital gains incentive fee is determined and paid annually with respect to cumulative realized capital gains (but not unrealized capital gains) to the extent such realized capital gains exceed realized and unrealized losses for such year. In addition, Saratoga Investment accrues, but does not pay, a capital gains incentive fee in connection with any unrealized capital appreciation, as appropriate. All capital gains incentive fees are presented within net investment income within the Consolidated Statements of Operations, but the associated realized and unrealized gains and losses that these incentive fees relate to, are excluded. As such, Saratoga Investment believes that adjusted net investment income, adjusted net investment income yield and adjusted net investment income per share is a useful indicator of operations exclusive of any capital gains incentive fee expense or reversal attributable to gains. The presentation of this additional information is not meant to be considered in isolation or as a substitute for financial results prepared in accordance with GAAP, and may be different from non-GAAP measures used by other companies. In addition, these non-GAAP measures are not based on any comprehensive set of accounting rules or principles. Pursuant to the requirements of Item 10(e) of Regulation S-K, the following table provides a reconciliation of net investment income to adjusted net investment income, net investment income yield to adjusted net investment income yield and net investment income per share to adjusted net investment income per share for the quarters ended May 31, 2025 and 2024.

---

| | | |
|:---|:---|:---|
|  | **For the Three Months Ended** | **For the Three Months Ended** |
|  | **May 31,<br> 2025** | **May 31,<br> 2024** |
| Net Investment Income | $10142033 | $14335005 |
| Changes in accrued capital gains incentive fee expense/ (reversal) | - | - |
| Adjusted net investment income | $10142033 | $14335005 |
| Net investment income yield | 10.3% | 15.5% |
| Changes in accrued capital gains incentive fee expense/ (reversal) | - | - |
| Adjusted net investment income yield <sup>(1)</sup> | 10.3% | 15.5% |
| Net investment income per share | $0.66 | $1.05 |
| Changes in accrued capital gains incentive fee expense/ (reversal) | - | - |
| Adjusted net investment income per share <sup>(2)</sup> | $0.66 | $1.05 |

---

(1) Adjusted net investment income yield is calculated as adjusted net investment income divided by average
net asset value.

(2) Adjusted net investment income per share is calculated as adjusted net investment income divided by weighted
average common shares outstanding.